RAS findings typical of severe COVID-19 included increased levels of the alternative RAS metabolites Ang 1–7 and Ang 1–5 [28] together with increased soluble ACE2 levels [29, 38] and ALT-S [28]. This evidence concerns the gene ACE2 and COVID-19.